Carlos Colombo presenting EB-5 visa US investor visas cannes expo
Colombo & Hurd, PL is honored to be a sponsor of the Cannes International Emigration & Luxury Property Expo on October 26th and 27th, 2017. The Cannes Expo is the world’s leading exhibition featuring companies from over 30 countries dedicated to immigration, luxury real estate, and private financial consulting and will be held at the Palais des Festivals et des Congrès in Cannes. France. Colombo & Hurd’s founding partner, Carlos M. Colombo, is one of the select speakers presenting “US Immigration Through Investment: Analyzing the Options from a Legal Standpoint” on October 27th at 10am. The presentation will focus on immigration options for potential US investors including the EB-5 Visa, E-2 Visa and the L-1 Visa. Mr. Colombo is honored to be the sole U.S. Immigration Attorney who will be presenting at the Expo. If you are attending the Expo please be sure to stop by our booth #33 and attend Mr. Colombo’s presentation.
- New York
Subscribe for News
Join Professionals on EB5Projects.com →
This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. EB5Projects.com LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.